Opendata, web and dolomites

Galastick

A medical device determining the daily amount of breast milk to improve neonatal nutrition andmothers’ psychophysics well-being.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Galastick project word cloud

Explore the words cloud of the Galastick project. It provides you a very rough idea of what is the project "Galastick" about.

breastmilk    midwiferies    certified    assessing    pharma    undermining    neonatal    market    few    breastfeed    uses    nutrition    breastfeeding    donate    reveals    integration    supervised    improves    colic    milk    health    industrialize    galascreen    absence    psychological    player    business    simply    analyte    progressively    mothers    confidence    preterm    proprietary    donor    certifications    feel    engineer    reduce    preliminary    newborn    medical    mother    people    depression    commercialization    device    flow    successfully    sme    omini    wellness    works    inadequate    150    diversity    stick    excess    medically    feeding    onset    lateral    detecting    reached    plan    amount    trl    babies    prototype    deep    warning    crying    biological    daily    lack    disposable    volunteer    lactation    nervousness    immunochromatographic    frequent    company    strategy    assay    galastick    starts    chain    human    samples    regulatory    tested    infants    screened    occurs    active    hospitals   

Project "Galastick" data sheet

The following table provides information about the project.

Coordinator
GALASCREEN SRLS 

Organization address
address: VIA SAVINIO ED. POLIFUNZIONALE DIPTO DI FARM
city: RENDE
postcode: 87036
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://talentlab.calabriainnova.it/galascreen/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.6. (SOCIETAL CHALLENGES - Europe In A Changing World - Inclusive, Innovative And Reflective Societies)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GALASCREEN SRLS IT (RENDE) coordinator 50˙000.00
2    OMINI PHARMA SOCIETA A RESPONSABILITA LIMITATA SEMPLIFICATA IT (BUSSERO MILANO) participant 0.00

Map

 Project objective

'Biological diversity among people, reveals that not all mothers are the same. For some of them (not a few) it occurs that they are not able to successfully breastfeed their babies. Breastfeeding without 'feeding' can cause frequent crying and colic in the newborn and nervousness in mothers, lack of confidence in their abilities and depression. A mother starts to feel inadequate, undermining her psychological wellness. On the other hand, several mothers have breastmilk in excess and could donate it to preterm infants in midwiferies, thus promoting the babies' health and reduce hospitals' costs. Galascreen developed a proprietary disposable medical device, GalaStick, determining the lactation onset and the progressively increasing daily amount of breastmilk. The stick uses a lateral flow immunochromatographic assay that works simply detecting the presence (or absence) of a target analyte in the human milk sample. Such an easy to use stick not only improves the neonatal nutrition (warning if any feeding integration is needed), but also the psychological well-being of the mother. GalaStick has reached TRL 6 since a preliminary prototype has been tested with real human milk samples. More than 150 volunteer mothers and human milk donor mothers were successfully screened. Galascreen requires funding to engineer and industrialize the stick prototype and to get it medically certified as a medical device. Both key processes will be supervised and supported by the SME partner Omini Pharma. Phase 1 project will address a deep study on business development strategy and will define the value chain and the commercialization plan, together with assessing the regulatory procedures and certifications to be obtained by both the product and the company in order to be an active player on the medical market.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GALASTICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GALASTICK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.6.;H2020-EU.2.3.1.)

Appytalent (2016)

Human Resource Management Tool Based on Emotional Intelligence

Read More  

YellowHarbour (2017)

Creating Partnerships between NGOs and Businesses

Read More  

PENSUMO (2017)

Savings Loyalty System Based on Micro-Contributions from Retailers

Read More